Login / Signup

Mortality and morbidity following postoperative use of short-term, low-dose quetiapine vs risperidone in patients with diabetes: Analysis using a national inpatient database.

Daisuke SatoKazuaki UdaRyosuke KumazawaHiroki MatsuiHideo Yasunaga
Published in: Pharmacoepidemiology and drug safety (2020)
In terms of mortality and infectious outcomes, safety of quetiapine and risperidone may be comparable.
Keyphrases
  • low dose
  • cardiovascular events
  • risk factors
  • patients undergoing
  • high dose
  • mental health
  • quality improvement
  • emergency department
  • type diabetes
  • cardiovascular disease
  • insulin resistance
  • weight loss